Organisation paid for research Program year 2025 Source: CMS Open Payments

Keystone Research

Neither a doctor nor a teaching hospital

Research payments

$149,549

32 payments

Through program year 2025, Keystone Research is reported as receiving $149,549 in research payments, across 32 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$42,726	1
2024	Research	$961	1
2023	Research	$23,808	23
2022	Research	$64,089	1
2020	Research	$13,265	2
2019	Research	$4,700	4

Breakdown

Who paid Research payments · program years 2019–2025

Alcon Research LLC $126,970 24 payments
Glaukos Corporation $13,265 2 payments
Kala Pharmaceuticals, Inc. $4,700 4 payments
Amneal Pharmaceuticals LLC $4,614 2 payments

Studies the money was for Research payments · program years 2019–2025

Negative Dysphotopsia $64,089 1 payment
Method Validation Study to Quantify Negative Dysphotopsia with Keystone Research $42,726 1 payment
The Hydrus Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm Clinical Trial $13,963 13 payments
iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study $13,265 2 payments
Clareon Toric vs Eyhance Toric $5,000 2 payments
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease $4,700 4 payments
Bimatoprost $4,614 2 payments
A Phase 3 Study Evaluating the Safety and Efficacy of AR-15512, a Cold Thermoreceptor Modulator, for the Treatment of Dry Eye Disease (COMET-3) $874 2 payments
Long-term evaluation of safety and performance of Clareon Presbyopia-Correction IOLs PMCF Study of Clareon Vivity and Clareon PanOptix $319 5 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.